Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease
Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease
Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease
Submitted by
admin
on May 31, 2011 - 12:39pm
Source:
Yahoo/AP
News Tags:
chronic kidney disease
Takeda
Hematide/peginesatide
Affymax
Headline:
Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease
Do Not Allow Advertisers to Use My Personal information
